The cell divides in a series of discrete steps that occur in a specific order. Lu and Cross (2010) now propose that cell-cycle events are ordered by a regulatory system in which a master oscillator, based on cyclin-dependent kinases, entrains a series of peripheral oscillators controlling individual events.
enzyme USP5, which selectively cleaves unanchored chains ( Figure 1A ; ReyesTurcu et al., 2006) , destroyed the ability of chains released from RIG-I CARD domains to promote pathway activation. Second, these chains were charged by the E1 ubiquitin-activating enzyme, which requires a free C-terminal glycine found in unanchored ubiquitin chains for charging.
The new work of Zeng et al. establishes a model in which RIG-I first senses a viral infection by binding to viral RNA through its RNA helicase domain, thereby exposing the tandem N-terminal CARD domains ( Figure 1B ). The exposed CARD domains then associate with unanchored K63-linked ubiquitin chains, thereby facilitating recognition of MAVS and activation of the IRF3 pathway. Although Zeng et al. (2010) convincingly demonstrate that unanchored K63-linked ubiquitin chains activate RIG-I, the underlying mechanism remains to be elucidated. As the CARD domain of MAVS cannot bind to ubiquitin directly, one possibility is that binding of ubiquitin to RIG-I reveals a surface within the RIG-I CARD domains that then interacts with MAVS. The origin and abundance of the unanchored chains also remains a mystery, although Zeng and coworkers provide data implicating TRIM25. It remains possible that a K63-linked ubiquitin chain is constructed on RIG-I itself (or on another substrate), and that this chain is then selectively liberated through the action of an unknown deubiquitinating enzyme (Figure 1) The plant toxin ricin and the bacterial Shiga toxins are among the most toxic compounds known to man. Shiga toxins, produced by pathogenic Escherichia coli and Shigella dysenteriae, cause dysentery in millions of people around the world every year; and, ricin, produced by the castor bean (Ricinus communis), gained notoriety when it was used to assassinate the Bulgarian journalist Georgi Markov in 1978. There are currently no known antidotes to Shiga toxin or ricin, and the potential use of ricin in a bioterror attack is of major concern. In this issue of Cell, Stechmann et al. (2010) , now identify two small molecules that protect cells against Shiga toxin or ricin by blocking the transport of the toxins from endosomes to the Golgi apparatus.
Shiga toxin and ricin are members of the AB chain toxins, which contain two protein subunits (Figure 1 To inhibit protein synthesis and induce cell death, plant ricin toxin and bacterial Shiga toxins enter the cell through the endocytic and retrograde secretory pathways. Stechmann et al. (2010) now identify two small-molecule inhibitors that selectively block endosome-to-Golgi retrieval of ricin and Shiga toxins and protect mice from ricin's deadly effects.
ribosomes in the cytoplasm. Shiga toxin and ricin both enter the cell by clathrindependent and clathrin-independent endocytosis, which delivers the toxins to early endosomes (Figure 1 ) (Spooner et al., 2006) . Next, the toxins escape from the endocytic system and are delivered to the Golgi apparatus by the endosometo-Golgi retrieval pathway. Finally, the toxins reach the endoplasmic reticulum (ER) via the retrograde pathway, where the A chains enter the cytoplasm to exert their toxic effects on protein synthesis. Understanding the mechanisms that govern the uptake and delivery of the AB chain toxins is of great interest, not only for the development of therapeutics against these toxins, but also because the B subunit is a useful biochemical tool for investigating the endocytic pathway. When expressed as a recombinant protein, the B chain traffics through the cell using essentially the same mechanism as endogenous cellular proteins, including the lysosomal hydrolase receptor CIMPR (cation-independent mannose-6-phosphate receptor) and the Golgi membrane protein TGN46. For example, endosome-to-Golgi retrieval of CIMPR (Seaman, 2004) and Shiga toxin (Bujny et al., 2007; Popoff et al., 2007) both require the retromer complex, an endosomal protein complex that sorts cargo into tubules (Figure 1) .
Using a high-throughput approach to screen over 16,000 small molecules, Stechmann et al. (2010) now identify two compounds, Retro-1 and Retro-2, that protect HeLa cells and human pulmonary epithelial cells against ricin-mediated cell death in vitro. The authors find that the compounds do not inhibit the binding of ricin to the cell or its catalytic activity. However, both Retro-1 and Retro-2 do protect HeLa cells against the inhibition of protein synthesis by Shiga toxin. Because ricin and Shiga toxin use essentially identical pathways to traverse the cell, the authors hypothesized that the protective effects of Retro-1 and Retro-2 probably occur during trafficking of the toxins from the cell surface to the ER.
To test this hypothesis, the authors used an immunofluorescence assay with the Shiga toxin B chain conjugated to a fluorescent tag. They found that both Retro-1 and Retro-2 specifically block the delivery of toxin from endosomes to the Golgi complex but do not affect other trafficking pathways, such as endocytosis or the secretory pathway (Figure 1 ). Most surprisingly, Retro-1 and Retro-2 appear to have no effect on other proteins that traffic between endosomes and the Golgi network, including CIMPR and TGN46. This implies that, at a particular point in the endosome-to-Golgi retrieval pathway, Shiga toxin B chain may be sorted away from other membrane proteins, such as CIMPR and TGN46. This separation likely occurs late in the endosome-to-Golgi pathway after protein-sorting complexes, such as retromer, have performed their function.
To identify the specific targets of the Retro-1 and Retro-2 compounds, Stechmann and colleagues characterized the cellular localization of 26 proteins present in either the endocytic pathway or the Golgi. They found that Retro-1 and Retro-2 altered the location of only two of these factors, the SNARE proteins syntaxin 5 and syntaxin 6. SNAREs are small (14-40 kDa) proteins containing coiledcoil motifs that associate with intracellular membranes to mediate the docking and fusion of transport vesicles. There are 38 SNAREs encoded in the human genome, with each SNARE localized to a defined set of membranes and responsible for a specific set of membrane fusion reactions (Bock et al., 2001) . Syntaxin 6, syntaxin 16, and syntaxin 5, along with vti1a, VAMP3, VAMP4, Ykt6, GS15, and GS28, are known to be needed for the figure 1. Trafficking of AB chain Toxins (Left) AB chain toxins, such as ricin and Shiga toxin, enter mammalian cells through both clathrin-dependent and clathrin-independent endocytosis. The toxins are then transported from endosomes to the Golgi network via a section of the secretory pathway (black arrows), called the retrograde pathway (red and black arrows), which requires the retromer complex. Ultimately, the toxins reach the endoplasmic reticulum (ER), where the A chain is cleaved from the B chain. The A chain then enters the cytoplasm, where it induces cell death by inhibiting protein synthesis. (Right) Two compounds, Retro-1 and Retro-2, selectively inhibit the endosome-to-Golgi retrieval of the AB chain toxins (Stechmann et al., 2010) , but they do not affect the retrograde trafficking of many endogenous proteins, such as CIMPR (cation-independent mannose-6-phosphate receptor). This suggests that Retro-1 and Retro-2 probably act downstream of the retromer complex. Retro-1 and Retro-2 perturb the localization of the SNARE proteins syntaxin 5 and (to a lesser extent) syntaxin 6, which mediate vesicle fusion in the Golgi network. transport of Shiga toxin from endosomes to the Golgi apparatus, with depletion of syntaxin 5 providing the best protection against Shiga toxin (Mallard et al., 2002; Tai et al., 2004; Amessou et al., 2007) .
Syntaxin 5 is localized primarily to the side of the Golgi that receives biosynthetic traffic from the ER (i.e., the cis side), but its localization extends through the Golgi toward the trans side (Figure 1 ; Hay et al., 1998) ; hence, syntaxin 5 is likely to function at multiple points between the Golgi and the ER. Therefore, the passage of ricin and Shiga toxin to their destination at the ER may be more sensitive to treatments that affect function and/or localization of syntaxin 5 than the retrieval of, for example, the CIMPR, which is delivered to the trans-Golgi.
How do Retro-1 and Retro-2 alter the localization of syntaxin 5? Stechmann et al. show that in cells treated with these small molecules, syntaxin 5 (and to a lesser extent syntaxin 6) relocates from the Golgi apparatus to small vesicles in the cytoplasm, a step that appears to be specific for these SNARE proteins. However, exactly where Retro-1 and Retro-2 act in the retrograde trafficking pathway is still not known. It is also unclear whether the relocalization of syntaxin 5 directly causes the block in endosome-to-Golgi transport of ricin and Shiga toxins or simply results from the inhibition of this pathway. Further, it will be important to determine if and how Retro-1 and Retro-2 affect the ability of these SNARE proteins to drive membrane fusion.
In a key experiment, Stechmann and coworkers show that Retro-2 protects mice from a lethal dose of ricin. To achieve this effect, however, Retro-2 had to be administered prior to ricin exposure, which may preclude the use of Retro-2 in treating individuals already exposed to ricin. Nevertheless, this result suggests that it may be possible to protect against ricin exposure or to treat Shigella infection with compounds that selectively block the transport of AB chain toxins in the endosome-toGolgi pathway. In addition, the toxin inhibitors identified by Stechmann et al. will be useful tools for unraveling the mechanistic details of endosome-to-Golgi transport of both endogenous proteins and toxic intruders.
Biological rhythms, from the beating of hearts to the flashing of fireflies, are driven by regulatory circuits called oscillators. The frequency of most biological oscillators-the heart rate, for example-can be adjusted by outside signals, allowing coordination of a periodic event with other events or with changes in the environment. Sometimes one oscillator is synchronized with another-as in the well-known case of our body's circadian rhythm, which is entrained to the light-dark cycle of the environment. In this issue of Cell, Lu and Cross (2010) take the problem of oscillator control into rich new territory. They provide evidence that a series of oscillators is governed by a single master oscillator to control the rhythms of the cell division cycle.
Orderly progression through the cell cycle is guided by cyclin-dependent kinases (Cdks) in association with oscillating cyclin subunits (Morgan, 2007) . We know a great deal about the regulators that generate the ups and downs of Cdk activity, but we have only a minimal understanding of how Cdks trigger cellcycle events in the correct order. One source of order can be found in "check-
